Your browser doesn't support javascript.
loading
A Retrospective Analysis of Factors Affecting Palliative Care Consults in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Rodriguez, Robin R; Babar, Laila; Lo, Herman; Ashraf, Obaid; Monga, Dulabh; Finley, Gene; Doverspike, Lisa; Blackledge, Amber; Sethi, Ashish; Raj, Moses S.
Afiliación
  • Rodriguez RR; Medical Oncology, Allegheny Health Network, Pittsburgh, USA.
  • Babar L; Medical Oncology, The University of Iowa Hospitals and Clinics, Iowa City, USA.
  • Lo H; Medical Oncology, Allegheny Health Network, Pittsburgh, USA.
  • Ashraf O; Internal Medicine, Allegheny Health Network, Pittsburgh, USA.
  • Monga D; Hematology and Oncology, Allegheny Health Network, Pittsburgh, USA.
  • Finley G; Hematology and Oncology, Allegheny Health Network, Pittsburgh, USA.
  • Doverspike L; Palliative Care, Butler Health System, Butler, USA.
  • Blackledge A; Palliative Care, Butler Health System, Butler, USA.
  • Sethi A; Medical Oncology, Allegheny Health Network, Pittsburgh, USA.
  • Raj MS; Hematology and Oncology, Allegheny Health Network, Pittsburgh, USA.
Cureus ; 13(1): e12589, 2021 Jan 09.
Article en En | MEDLINE | ID: mdl-33575150
ABSTRACT
Purpose This study was conducted to determine factors that influence palliative care (PC) consultation in patients receiving cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). Patient and methods We queried our Electronic Medical Record EPIC for a list of patients who underwent cytoreductive surgery with HIPEC or hyperthermic intrathoracic chemotherapy (HITEC) in the hospital from April 2016-April 2019. Data was manually extracted and patients who did not meet our criteria were excluded. Patients were divided on the basis of palliative care consults and differences between the groups were analyzed. Odds ratios (OR) with p-value of 0.05 and confidence interval of (CI) 95% were calculated. Results We identified 55 patients of whom 34 met our inclusion criteria 11 males and 23 females with an average age of 56 years at the time of diagnosis. Eight patients (23%) had PC, with six having commercial insurance, seven married, and six with more than one comorbid medical issue. Comorbidities >1 (OR 0.12; CI 0.02-0.76; p 0.02) and age >40 (OR 0.015; CI 0.0007-0.3029; P 0.006) were associated with a higher likelihood of PC. Gender, insurance type, and marital status did not have a significant association with PC. Mean age between PC consulted patients versus non-PC consulted patients was 58.5 vs. 55.9 and median age between the two groups was 60.5 vs. 60 which also showed a trend towards higher rates of PC in the older population. Conclusion Approximately one quarter of patients who underwent CRS with HIPEC had a concurrent PC consult. Though this is better than the national average of 11-16%, it continues to be a very small number. Efforts must be made to engage PC early in the course of treatment and recognize it as an integral part of cancer care. PC is not only an end-of-life service, in fact, studies have shown that early consultations lead to higher patient satisfaction, improved quality of life, and better communication.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_sistemas_informacao_saude Tipo de estudio: Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: Cureus Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_sistemas_informacao_saude Tipo de estudio: Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: Cureus Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
...